Peng PENG, Yang XIANG. Reflecting the Achievements of Practice and Leading the Future Direction: Interpretation on Cervical Cancer Staging of the International Federation of Obstetrics and Gynecology in 2018[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 12-15. DOI: 10.3969/j.issn.1674-9081.20190164
Citation: Peng PENG, Yang XIANG. Reflecting the Achievements of Practice and Leading the Future Direction: Interpretation on Cervical Cancer Staging of the International Federation of Obstetrics and Gynecology in 2018[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 12-15. DOI: 10.3969/j.issn.1674-9081.20190164

Reflecting the Achievements of Practice and Leading the Future Direction: Interpretation on Cervical Cancer Staging of the International Federation of Obstetrics and Gynecology in 2018

More Information
  • Corresponding author:

    XIANG Yang Tel: 86-10-69156204, E-mail:xiangy@pumch.cn

  • Received Date: August 06, 2019
  • Issue Publish Date: January 29, 2020
  • For years, the cervical cancer staging of the International Federation of Gynecology and Obstetrics (FIGO) are of clinical staging. However, with the development of diagnostic techniques, advances in surgical procedures, and a deeper understanding of the prognosis of cervical cancer, the old FIGO staging has not been able to well predict the prognosis of cervical cancer and to help the choice of treatment. Therefore, on the basis of the cervical cancer staging in 2009, FIGO introduced new progress in the diagnosis and treatment of cervical cancer in the past 10 years and formed the new staging of cervical cancer in 2018. The new staging system mainly reflects a more detailed stratification of the tumor size and the inclusion of lymph node metastasis. This article explains the changes in the cervical cancer staging of FIGO 2018 and its clinical significance.
  • [1]
    Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J]. Int J Gynaecol Obstet, 2009, 105:103-104. DOI: 10.1016/j.ijgo.2009.02.012
    [2]
    Bhatla N, Denny L.FIGO Cancer Report 2018[J]. Int J Gynaecol Obstet, 2018, 143:2-3. https://www.ncbi.nlm.nih.gov/pubmed/30306587
    [3]
    Matsuo K, Machida H, Mandelbaum RS, et al. Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm:trends and characteristics in the United States[J]. J Gynecol Oncol, 2018, 29:e85.
    [4]
    Machida H, Mandelbaum RS, Mikami M, et al. Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer:trachelectomy vs hysterectomy[J]. Am J Obstet Gynecol, 2018, 219:461.e1-461.e18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648708/
    [5]
    Li J, Wu X, Li X, et al. Abdominal radical trachelectomy:Is it safe for IB1 cervical cancer with tumors >/=2 cm?[J]. Gynecol Oncol, 2013.131:87-92. DOI: 10.1016/j.ygyno.2013.07.079
    [6]
    Plante M.Evolution in fertility-preserving options for early-stage cervical cancer:radical trachelectomy, simple trachelectomy, neoadjuvant chemotherapy[J]. Int J Gynecol Cancer, 2013, 23:982-989. DOI: 10.1097/IGC.0b013e318295906b
    [7]
    Marchiole P, Benchaib M, Buenerd A, et al. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation):a comparative study with laparoscopic-assisted vaginal radical hysterectomy(LARVH)[J]. Gynecol Oncol, 2007, 106:132-141. DOI: 10.1016/j.ygyno.2007.03.009
    [8]
    Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?[J]. Gynecol Oncol, 2004, 92:525-529. DOI: 10.1016/j.ygyno.2003.11.020
    [9]
    Selman TJ, Mann C, Zamora J, et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer:a systematic review and meta-analysis[J]. CMAJ, 2008, 178:855-862. DOI: 10.1503/cmaj.071124
    [10]
    Singh N, Arif S.Histopathologic parameters of prognosis in cervical cancer-a review[J]. Int J Gynecol Cancer, 2004, 14:741-750.
    [11]
    Ramirez PT, Jhingran A, Macapinlac HA, et al.Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer:a prospective correlation of surgical findings with positron emission tomography/computed tomography findings[J]. Cancer, 2011, 117:1928-1934. DOI: 10.1002/cncr.25739
    [12]
    Pol FJ, Zusterzeel PL, van Ham MA, et al.Satellite lymphovascular space invasion:An independent risk factor in early stage cervical cancer[J]. Gynecol Oncol, 2015, 138:579-584. DOI: 10.1016/j.ygyno.2015.06.035
    [13]
    Hutchcraft ML, Smith B, McLaughlin EM, et al.Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer[J]. Gynecol Oncol, 2019, 153:255-258. DOI: 10.1016/j.ygyno.2019.01.026
    [14]
    Sedlis A, Bundy BN, Rotman MZ, et al.A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy:A Gynecologic Oncology Group Study[J]. Gynecol Oncol, 1999, 73:177-183. DOI: 10.1006/gyno.1999.5387
    [15]
    Matsuo K, Machida H, Mandelbaum RS, et al. Validation of the 2018 FIGO cervical cancer staging system[J]. Gynecol Oncol, 2019, 152:87-93. DOI: 10.1016/j.ygyno.2018.10.026
    [16]
    Wright JD, Matsuo K, Huang Y, et al.Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines[J]. Obstet Gynecol, 2019, 134:49-57. DOI: 10.1097/AOG.0000000000003311
    [17]
    Ayhan A, Aslan K, Oz M, et al. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer[J]. Arch Gynecol Obstet, 2019, 300:675-682. DOI: 10.1007/s00404-019-05232-7
  • Related Articles

    [1]JIANG Nan, TIAN Xinping, ZENG Xiaofeng. Interpretation on the 2024 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 28-34. DOI: 10.12290/xhyxzz.2024-1018
    [2]ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605
    [3]JIN Shangyi, TIAN Xinping. Interpretation on the Chinese Guideline for the Diagnosis and Treatment of Takayasu's Arteritis (2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 560-566. DOI: 10.12290/xhyxzz.2024-0209
    [4]LIANG Yan. Interpretation on the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 312-319. DOI: 10.12290/xhyxzz.2024-0043
    [5]JIA Zhimeng, Rebecca Colman, NING Xiaohong. Interpretation on Management of Dyspnea in Advanced Cancer: ASCO Guideline[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 52-57. DOI: 10.12290/xhyxzz.2023-0517
    [6]ZUO Wei, LIU Rongji, SUN Yajia, ZHANG Bo, CHEN Yaolong, ZHANG Shuyang. Interpretation on Management Guideline for the Off-label Use of Drugs in China(2021 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 86-93. DOI: 10.12290/xhyxzz.2022-0588
    [7]LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
    [8]ZHAO Weigang. Interpretation on Clinical Guidelines for Prevention and Treatment of Type 2 Diabetes Mellitus in the Elderly in China (2022 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 574-580. DOI: 10.12290/xhyxzz.2022-0199
    [9]Wei WANG, Ling-ya PAN. The Concept of Evidence-based Medicine Leads to Better Clinical Outcomes: Guidelines for Enhanced Recovery after Surgery in Gynecologic/ Oncology 2019 Update and Interpretation[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 582-588. DOI: 10.3969/j.issn.1674-9081.2019.06.006
    [10]Jian-chun YU, Zhi-gang XUE. Active Assessment and Intervention:Issues of Clinical Nutrition in Guidelines for Enhanced Recovery after Gastrointestinal Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 490-495. DOI: 10.3969/j.issn.1674-9081.2018.06.003
  • Cited by

    Periodical cited type(3)

    1. 李立茵. PACU低体温患者中西医结合护理研究进展. 贵州中医药大学学报. 2023(01): 87-90 .
    2. 汪梦鑫,曹世华,乐宇超,陈正,钱倍颖,何丹妮,陈彦菲. 无线持续体温监测在重症感染护理中的应用进展. 物联网技术. 2021(09): 110-113 .
    3. 张董瑜,冯琪,邵长会,黄维艳,欧珊. 围术期全程闭环体温管理系统预防老年股骨颈骨折患者低体温的效果. 中华创伤杂志. 2021(12): 1119-1125 .

    Other cited types(1)

Catalog

    Article Metrics

    Article views (434) PDF downloads (359) Cited by(4)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close